Sep 29, 2025 09:15AM Autonomix Medical begins preclinical study for pancreatic cancer device

Sep 4, 2025 07:00AM Innovation and IP in Medtech Stocks - How Patents Build Leaders

Aug 14, 2025 08:31AM Autonomix Medical completes design review for nerve sensing catheter

Jul 22, 2025 08:40AM JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live

Jul 22, 2025 08:33AM Autonomix Medical raises $2.5M through warrant exercise agreements

Jul 21, 2025 08:45AM Autonomix Medical receives patent for smart torquer device

Jun 27, 2025 08:01AM Autonomix Medical (AMIX) Granted New U.S. Patent for Innovative Catheter-Based Platform Technology

Jun 5, 2025 08:45AM Autonomix Medical (AMIX) Granted Approval to Expand Proof-of-Concept Human Clinical Study

May 13, 2025 09:21AM Autonomix Medical (AMIX) CEO Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable Market

May 5, 2025 08:32AM Autonomix Medical (AMIX) Highlights Compelling Patient Testimonial Showing Rapid Pain Relief from First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain

Apr 30, 2025 08:15AM Autonomix Medical (AMIX) Reports Positive Outcomes in Initial Phase of First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain

Apr 16, 2025 08:32AM Autonomix Medical (AMIX) Granted New European Patent for Proprietary Catheter-Based Technology

Apr 8, 2025 08:15AM Autonomix Medical (AMIX) Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain

Mar 14, 2025 08:31AM Autonomix Medical (AMIX) Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation

Jan 17, 2025 08:02AM Autonomix Medical (AMIX) Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Nov 22, 2024 09:17AM Autonomix Medical (AMIX) Announces Pricing of $9.0 Million Underwritten Public Offering

Nov 1, 2024 09:06AM Autonomix Medical (AMIX) Files for 698.81K Share and Warrant Offering

Oct 31, 2024 08:06AM Autonomix Medical (AMIX) Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction

Oct 28, 2024 08:03AM Autonomix Medical (AMIX): Positive Preliminary Results Demonstrate Autonomix’s Proprietary RF Ablation Technology’s Ability to Reduce Opioid Use in Ongoing Human Clinical Trial

Oct 22, 2024 08:31AM Autonomix Medical (AMIX) Announces 1-for-20 Reverse Stock Split

Sep 9, 2024 07:01AM Autonomix Medical (AMIX) Announces 83% Reduction of Pain at 4-6 Week Follow-Up from Lead-In Patients in Ongoing Human Clinical Trial in Pancreatic Cancer Pain Patients

Jul 24, 2024 08:02AM Autonomix Medical (AMIX) Completes Licensing Transaction for FDA-Cleared Ablation Technology

Jul 15, 2024 08:01AM Autonomix Medical (AMIX) Enters into Definitive Agreement to License Intellectual Property for FDA-Cleared Ablation Technology from RF Innovations, Inc.

Jun 18, 2024 08:03AM Autonomix Medical (AMIX) Announces Positive Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial

Jun 17, 2024 04:06PM Autonomix Medical (AMIX) Names Brad Hauser as President and Chief Executive Officer